These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6246428)

  • 1. Progress in vasodilator therapy for heart failure.
    Cohn JN
    N Engl J Med; 1980 Jun; 302(25):1414-6. PubMed ID: 6246428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of chronic heart failure with vasodilator agents].
    Zähringer J; Schultheiss HP
    Internist (Berl); 1986 May; 27(5):315-21. PubMed ID: 3015822
    [No Abstract]   [Full Text] [Related]  

  • 3. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of congestive heart failure (2). Diuretic administration and vasodilator therapy of cardiac asthma and pulmonary edema (cardiac load reduction) with special reference to SQ 14225 (captopril)].
    Takatsu T; Tsutsumi J; Kubo S; Kino M; Nishioka A; Suwa M; Morita H; Hirota Y; Kitaura Y; Kawamura K
    Nihon Rinsho; 1980 Feb; 38(2):408-31. PubMed ID: 6993729
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with captopril in severe heart ventricular failure].
    Arnman K; Cavalli-Björkman U; Rydén L; Smedgård P
    Lakartidningen; 1982 Dec; 79(51):4829-31. PubMed ID: 6759818
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of captopril in the management of cardiac failure.
    Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
    Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 8. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
    Packer M
    Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Captopril in the treatment of heart failure].
    Kékes E
    Acta Pharm Hung; 1997 Jul; 67(4):155-63. PubMed ID: 9289944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effect of captopril in a patient with congestive heart failure and ischemic interventricular septal rupture.
    Cintrón G; Rivera del Río JR; Aranda JM; Hernández-López E; Linares E; Ramírez EA
    Bol Asoc Med P R; 1983 Feb; 75(2):73-4. PubMed ID: 6347216
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 18. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
    Yui Y; Kawai C
    Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
    Awan NA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.